Drug intelligence / Profile preview

Zhichuanling

Development stage
Unknown
Lead developer
Suzhong Pharmaceutical
Administration
Intramuscular, Oral
01

Overview

Zhichuanling is a multi-component traditional Chinese medicine (TCM) formulation widely used in China for the treatment of respiratory conditions such as bronchial asthma and acute exacerbation of chronic obstructive pulmonary disease (AECOPD). It is available in both injection and oral liquid forms. The oral liquid is primarily composed of extracts from Mahuang (Herba Ephedrae), Yangjinhua (flower of Datura metel L.), bitter almond (Semen Armeniacae Amarum), and Forsythia (Fructus Forsythiae). Its therapeutic effects are attributed to its ability to reduce airway inflammation, inhibit airway remodeling and mucus secretion, relieve cough, and relax bronchial smooth muscle spasm. Zhichuanling also exhibits antagonistic effects against cholinergic neurotransmitters like acetylcholine and inflammatory mediators such as histamine, thereby improving lung ventilation and overall lung function. Its complex mechanism of action involves modulating multiple signaling pathways, including NF-κB, PI3K/Akt, IL-17, Toll-like receptor, and TNF pathways, and it can restore Ca2+ homeostasis and suppress endoplasmic reticulum stress through inhibition of the STIM1/CHOP/JNK axis.

Brand names
Zhichuanling
Other names
止喘灵
02

Targets

H (Histamine receptors)ChoP (Phosphorylcholine)BPIFA1 (BPI fold-containing family A member 1)STIM1 (Stromal interaction molecule 1)AChR (Acetylcholine receptor)JNK (Mitogen-activated protein kinase kinase kinase family)

Beyond the preview

Go deeper on Zhichuanling.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhichuanling.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call